Home  |  Site Map  |  Glossary  | Contact
Text size: AA   AA   AA

Press Releases

2009 Press Releases

Listed below are all of the QLT press releases available for the year you have selected.

December 30 QLT Acquires Early-Stage Ophthalmic Asset for US$7.5 Million PDF version
December 22

QLT Inc. Establishes Sales Force in the United States

PDF version
December 15 QLT Initiates Phase Ib Study of QLT091001 in Leber Congenital Amaurosis PDF version
December 09 6-Month Results from EVEREST Study Evaluating Visudyne® Therapy in Patients with Polypoidal Choroidal Vasculopathy PDF version
November 25 QLT Announces MGH Litigation Settlement PDF version
October 28 QLT Announces Toronto Stock Exchange Approval of Share Repurchase Program PDF version
October 27 QLT Announces Share Repurchase Program PDF version
October 27 QLT Announces Third Quarter Results for 2009                                                    PDF version
October 19

QLT Restructures Visudyne® Agreement

PDF version
October 01 QLT Announces Sale of QLT USA, Inc. For Up to US$230 Million PDF version
September 08 QLT Announces Receipt of a CDN$45.3 Million Tax Refund PDF version
July 28 QLT Announces Second Quarter Results for 2009 PDF version
July 28 QLT Announces Interim Data From a Phase II Clinical Trial and a Device Study for the Punctal Plug Drug Delivery System PDF version

June 15

QLT Announces 12-Month Results From Novartis Sponsored MONT BLANC Study Evaluating Standard-Fluence Visudyne® Combination Therapy

PDF version

June 02

QLT Announces Positive Results From the Evaluation of Visudyne® Combination Therapy

PDF version

May 21

QLT Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court

PDF version

April 28

QLT Announces First Quarter Results for 2009

PDF version

March 26

QLT Names Kathryn Falberg to the Board of Directors

PDF version

March 12

QLT Announces Completion of Phase Ia Safety Trial of Its Synthetic Retinoid Product

PDF version

February 24

QLT Petition For Rehearing of Massachusetts Eye and Ear Infirmary Litigation is Denied

PDF version

February 19

QLT Announces Fourth Quarter and Year End 2008 Results

PDF version

February 12

QLT Announces That It is Named as a Defendant in an Action

PDF version

January 30

QLT Announces Final Results of Tender Offer

PDF version

January 27

QLT Announces Preliminary Results of Tender Offer

PDF version

January 15

QLT Announces New Expiration Date of Dutch Tender

PDF version

January 12

QLT Announces Appeal Court Decision on Massachusetts Eye and Ear Infirmary Litigation

PDF version

January 12

QLT Announces Visudyne® Sales for Fourth Quarter and Fiscal Year 2008

PDF version

Visudyne® is a registered trademark of Novartis AG
 
Copyright © 2000-2009 QLT Inc. Legal Terms for use of site and Privacy Policy | Disclaimer
Vancouver Web Design by Graphically Speaking